Re-engineering the clinical approach to suspected cardiac chest pain assessment; extending chest pain research evidence to the pre-hospital setting, enabled by novel point of care high-sensitivity cardiac troponin I (hs-cTnI) and artificial intelligence.

Authors
Category Primary study
Registry of TrialsAustralian New Zealand Clinical Trials Register
Year 2022
This article has no abstract
Epistemonikos ID: 79ed401537312ad35cbfcc5477e01580d135e110
First added on: Mar 18, 2025